Editorial & Opinion
Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient.
| العنوان: | Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient. |
|---|---|
| المؤلفون: | Yiğit Kaya S; Department of Hematology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey. sureyyayigitkaya@hotmail.com., Bektas S; Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey., Askin AE; Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey., Balık Aydın B; Gazi Yaşargil Education Research Hospital, Diyarbakir, Turkey., Mutlu YG; Department of Hematology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey., Sevindik ÖG; Department of Hematology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey. |
| المصدر: | Annals of hematology [Ann Hematol] 2023 Jun; Vol. 102 (6), pp. 1599-1600. Date of Electronic Publication: 2023 Apr 26. |
| نوع المنشور: | Letter |
| اللغة: | English |
| بيانات الدورية: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Berlin : Springer Verlag Original Publication: Berlin ; New York : Springer International, c1991- |
| مواضيع طبية MeSH: | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Hematopoietic Stem Cell Transplantation*, Humans ; T-Lymphocytes |
| References: | Marks DI, Rowntree C (2017) Management of adults with T-cell lymphoblastic leukemia. Blood 129(9):1134–1142. (PMID: 10.1182/blood-2016-07-69260828115371) Wan CL, Zou JY, Qiao M et al (2021) Venetoclax combined with azacitidine as an effective and safe salvage regimen for relapsed or refractory T-cell acute lymphoblastic leukemia: a case series. Leuk Lymphoma 62(13):3300–3303. (PMID: 10.1080/10428194.2021.195787634323656) Candoni A, Lazzarotto D, Ferrara F et al (2020) Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study. Am J Hematol 95(12):1466–1472. (PMID: 10.1002/ajh.2595732777149) Baek DW, Lee JM, Kim J et al (2021) Therapeutic strategies, including allogeneic stem cell transplantation, to overcome relapsed/refractory adult T-cell acute lymphoblastic leukemia. Expert Rev Hematol 14(8):765–775. (PMID: 10.1080/17474086.2021.196081734313508) Richard-Carpentier G, Jabbour E, Short NJ et al (2020) Clinical experience with venetoclax combined with chemotherapy for relapsed or refractory T-cell acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk 20(4):212–218. (PMID: 10.1016/j.clml.2019.09.60832035785) Farhadfar N, Li Y, May WS et al (2021) Venetoclax and decitabine for treatment of relapsed T-cell acute lymphoblastic leukemia: a case report and review of literature. Hematol Oncol Stem Cell Ther 14(3):246–251. (PMID: 10.1016/j.hemonc.2019.10.00232199933) McEwan A, Pitiyarachchi O, Viiala N (2020) Relapsed/refractory ETP-ALL successfully treated with venetoclax and nelarabine as a bridge to allogeneic stem cell transplant. HemaSphere 4(3):e379. (PMID: 10.1097/HS9.0000000000000379326477987306301) Candoni A, Lazzarotto D, Petruzzellis G (2021) Safety of nelarabine in adults with relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoma. Expert Opin Drug Saf 20(7):751–756. (PMID: 10.1080/14740338.2021.191962133866913) Kathpalia M, Mishra P, Bajpai R et al (2022) Efficacy and safety of nelarabine in patients with relapsed or refractory T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis. Ann Hematol 101(8):1655–2166. (PMID: 10.1007/s00277-022-04880-135727338) Heo YA, Syed YY, Keam SJ (2019) Pegaspargase: a review in acute lymphoblastic leukaemia. Drugs 79(7):767–777. (PMID: 10.1007/s40265-019-01120-1310303806531401) |
| المشرفين على المادة: | 7D96IR0PPM (pegaspargase) 60158CV180 (nelarabine) N54AIC43PW (venetoclax) |
| تواريخ الأحداث: | Date Created: 20230426 Date Completed: 20230515 Latest Revision: 20230515 |
| رمز التحديث: | 20240628 |
| DOI: | 10.1007/s00277-023-05231-4 |
| PMID: | 37099080 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1432-0584 |
|---|---|
| DOI: | 10.1007/s00277-023-05231-4 |